XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Treasury stock
Beginning balance (in shares) at Dec. 31, 2019     104,100          
Beginning balance at Dec. 31, 2019 $ 9,491.9 $ (1.7) $ 1.1 $ 1,903.9 $ 7,818.0 $ (1.7) $ (212.8) $ (18.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting standards update [Extensible List] Accounting Standards Update 2016-13 [Member]              
Net earnings $ 949.7       949.7      
Stock option exercises (in shares)     700          
Stock option exercises 105.5     105.5        
Treasury stock sold 10.5     10.2       0.3
Currency translation adjustments, including tax provision (benefit) 65.8 [1]           65.8  
Stock based compensation 119.0     119.0        
Restricted stock activity (in shares)     100          
Restricted stock activity (41.1)     (41.1)        
Dividends declared (219.8)       (219.8)      
Ending balance (in shares) at Dec. 31, 2020     104,900          
Ending balance at Dec. 31, 2020 10,479.8   $ 1.1 2,097.5 8,546.2   (147.0) (18.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net earnings $ 1,152.6       1,152.6      
Stock option exercises (in shares) 537   500          
Stock option exercises $ 104.7     104.7        
Cash settlement of share-based awards in connection with disposition of discontinued operations (6.7)     (6.7)        
Treasury stock sold 15.1     14.7       0.4
Currency translation adjustments, including tax provision (benefit) (36.1) [1]           (36.1)  
Stock based compensation 138.0     138.0        
Restricted stock activity (in shares)     100          
Restricted stock activity (40.4)     (40.4)        
Dividends declared $ (243.2)       (243.2)      
Ending balance (in shares) at Dec. 31, 2021 105,500   105,500          
Ending balance at Dec. 31, 2021 $ 11,563.8   $ 1.1 2,307.8 9,455.6   (183.1) (17.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net earnings $ 4,544.7       4,544.7      
Stock option exercises (in shares) 460   500          
Stock option exercises $ 110.0     110.0        
Cash settlement of share-based awards in connection with disposition of discontinued operations (11.1)     (11.1)        
Treasury stock sold 14.3     13.9       0.4
Currency translation adjustments, including tax provision (benefit) (3.9) [1]           (3.9)  
Stock based compensation 131.4     131.4        
Restricted stock activity (in shares)     100          
Restricted stock activity (41.8)     (41.8)        
Dividends declared $ (269.6)       (269.6)      
Ending balance (in shares) at Dec. 31, 2022 106,100   106,100          
Ending balance at Dec. 31, 2022 $ 16,037.8   $ 1.1 $ 2,510.2 $ 13,730.7   $ (187.0) $ (17.2)
[1] In connection with the Indicor Transaction, we reclassified $142.6 of foreign currency translation adjustments to “Gain on disposition of discontinued operations, net of tax” during the year ended December 31, 2022.